ImmunityBio
IBRX
ImmunityBio (IBRX) earnings history
Most recent quarter
- Fiscal period
- Q4 2025
- Period end
- Dec 31, 2025
- EPS actual
- −$0.06
- EPS estimate
- −$0.08
- EPS surprise
- +21.57%
- Revenue surprise
- −0.20%
- Revenue
- $38.3M
- Revenue estimate
- $38.4M
- Reported
- Feb 23, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Feb 23, 2026 | −$0.08 | −$0.06 | +21.57% | $38.3M | SEC |
| Q2 2025 | Aug 5, 2025 | −$0.11 | −$0.10 | +7.41% | $26.4M | SEC |
| Q1 2025 | May 12, 2025 | −$0.13 | −$0.15 | −17.19% | $16.5M | SEC |
| Q4 2024 | Mar 3, 2025 | −$0.20 | −$0.09 | +55.00% | $7.6M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.18 | −$0.14 | +21.35% | $6.1M | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.16 | −$0.20 | −25.00% | $1.0M | SEC |
| Q1 2024 | May 9, 2024 | −$0.20 | −$0.20 | −2.56% | $0.00 | SEC |
| Q4 2023 | Mar 19, 2024 | −$0.18 | −$0.36 | −100.00% | $119,500.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.26 | −$0.19 | +25.49% | $82,000.00 | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.24 | −$0.32 | −36.17% | $41,000.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.27 | −$0.27 | +0.00% | $400,000.00 | SEC |
| Q1 2022 | May 10, 2022 | −$0.22 | −$0.26 | −18.18% | $14,000.00 | — |
| Q1 2020 | May 11, 2020 | −$0.17 | −$0.19 | −11.76% | $21,000.00 | — |
Quarterly revenue
Frequently asked questions
When did ImmunityBio (IBRX) last report earnings?
ImmunityBio last reported on Feb 23, 2026, covering fiscal Q4 2025.
Did IBRX beat earnings estimates?
Yes. ImmunityBio reported EPS of −$0.06 for Q4 2025 against a −$0.08 estimate — a 21.57% beat.
How much revenue did IBRX report last quarter?
ImmunityBio reported $38.3M in revenue for Q4 2025, against a consensus estimate of $38.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.